1
|
Parsons DW, Jones S, Zhang X, et al: An
integrated genomic analysis of human glioblastoma multiforme.
Science. 321:1807–1812. 2008. View Article : Google Scholar : PubMed/NCBI
|
2
|
Furnari FB, Fenton T, Bachoo RM, et al:
Malignant astrocytic glioma: genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
Wang Y, Li S, Chen L, et al: Glioblastoma
with an oligodendroglioma component: distinct clinical behavior,
genetic alterations, and outcome. Neuro Oncol. 14:518–525. 2012.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Zhang W, Zhang J, Yan W, et al:
Whole-genome microRNA expression profiling identifies a 5-microRNA
signature as a prognostic biomarker in Chinese patients with
primary glioblastoma multiforme. Cancer. 119:814–824. 2013.
View Article : Google Scholar
|
5
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Hannon GJ: RNA interference. Nature.
418:244–251. 2002. View
Article : Google Scholar : PubMed/NCBI
|
7
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Bao YP, Yi Y, Peng LL, et al: Roles of
microRNA-206 in osteosarcoma pathogenesis and progression. Asian
Pac J Cancer Prev. 14:3751–3755. 2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wang X, Ling C, Bai Y and Zhao J:
MicroRNA-206 is associated with invasion and metastasis of lung
cancer. Anat Rec (Hoboken). 294:88–92. 2011. View Article : Google Scholar
|
10
|
Kondo N, Toyama T, Sugiura H, Fujii Y and
Yamashita H: miR-206 Expression is down-regulated in estrogen
receptor alpha-positive human breast cancer. Cancer Res.
68:5004–5008. 2008. View Article : Google Scholar : PubMed/NCBI
|
11
|
Miyachi M, Tsuchiya K, Yoshida H, et al:
Circulating muscle-specific microRNA, miR-206, as a potential
diagnostic marker for rhabdomyosarcoma. Biochem Biophys Res Commun.
400:89–93. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Yan D, da Dong XE, Chen X, et al:
MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma
development. J Biol Chem. 284:29596–29604. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Li Y, Hong F and Yu Z: Decreased
expression of microRNA-206 in breast cancer and its association
with disease characteristics and patient survival. J Int Med Res.
41:596–602. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Carmell MA, Xuan Z, Zhang MQ and Hannon
GJ: The Argonaute family: tentacles that reach into RNAi,
developmental control, stem cell maintenance, and tumorigenesis.
Genes Dev. 16:2733–2742. 2002. View Article : Google Scholar : PubMed/NCBI
|
15
|
Wightman B, Ha I and Ruvkun G:
Posttranscriptional regulation of the heterochronic gene lin-14 by
lin-4 mediates temporal pattern formation in C. elegans. Cell.
75:855–862. 1993. View Article : Google Scholar : PubMed/NCBI
|
16
|
Gao J, Wang WY, Mao YW, et al: A novel
pathway regulates memory and plasticity via SIRT1 and miR-134.
Nature. 466:1105–1109. 2010. View Article : Google Scholar : PubMed/NCBI
|
17
|
Shi ZM, Wang XF, Qian X, et al: MiRNA-181b
suppresses IGF-1R and functions as a tumor suppressor gene in
gliomas. RNA. 19:552–560. 2013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Zhang L, Liu X, Jin H, et al: miR-206
inhibits gastric cancer proliferation in part by repressing
cyclinD2. Cancer Lett. 332:94–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Dehay C and Kennedy H: Cell-cycle control
and cortical development. Nat Rev Neurosci. 8:438–450. 2007.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Sherr CJ: Mammalian G1 cyclins. Cell.
73:1059–1065. 1993. View Article : Google Scholar : PubMed/NCBI
|
21
|
Sherr CJ and Roberts JM: Living with or
without cyclins and cyclin-dependent kinases. Genes Dev.
18:2699–2711. 2004. View Article : Google Scholar : PubMed/NCBI
|